C-reactive protein as a possible modifier of Lipoprotein(a)-related risk for coronary heart disease in Europe: Results from the BiomarCARE project

Back

ESC Professional Premium Access

C-reactive protein as a possible modifier of Lipoprotein(a)-related risk for coronary heart disease in Europe: Results from the BiomarCARE project

Session: Cardiovascular risk assessment - Biomarkers 1

Topic: Biomarkers

Speaker: Doctor N. Arnold (Hamburg, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Natalie Arnold

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

0 follower

7 more presentations in this session

Lp(a) is not associated with arterial stiffness: A Mendelian Randomization Study.

Speaker: Doctor E. Maneta (Salt Lake City, US)

Access

Abstract

Slides

Investigation of type 1 collagen a1 chain in plasma as a potential novel biomarker for prediction of coronary heart disease

Speaker: Mr F. Hammareus (Linkoping, SE)

Access

Abstract

Slides

Clinical significance of undetectable high sensitivity cardiac troponin I (hs-TnI) in Thai individuals with low cardiovascular risk.

Speaker: Ms P. Sabkaewyod (Bangkok, TH)

Access

Abstract

Slides

Physical activity during adolescence and early adulthood and adult cardiometabolic risk profile: a longitudinal study

Speaker: Mrs S. Soendergaard (Herning, DK)

Access

Abstract

Slides

Trans fatty acid blood levels and HFpEF phenotype: from the Aldo-DHF RCT

Speaker: Doctor K. Lechner (Munich, DE)

Access

Abstract

Slides

Access the full session

Cardiovascular risk assessment - Biomarkers 1

Speakers: Doctor N. Arnold, Doctor E. Maneta, Mr F. Hammareus, Ms P. Sabkaewyod, Mrs S. Soendergaard...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources